Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
210
Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ<sub>m</sub> decrease.
Published 2013“…The sizes of immunoreactive bands are indicated. (<b>C, D</b>) Intensities of the cytochrome c signals in mitochondrial (mito) and cytosolic (cyto) fractions shown in panels A and B were quantified in HBMEC (<b>C</b>) and Caco-2 cells (<b>D</b>) using densitometry, expressed in arbitrary densitometric units (DU) and are presented as means ± standard deviations from three independent experiments. * Significantly decreased (<i>p</i><0.05) compared to mitochondrial cytochrome c in control cells; ** significantly increased (<i>p</i><0.05) compared to cytosolic cytochrome c in control cells (unpaired Student's <i>t</i> test). …”
-
211
-
212
-
213
Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1.
Published 2021“…(C) Decrease in ISC markers, OLFM4 and SOX9 in <i>Mll1</i><sup><i>FC/FC; Vil-Cre-ERT2/+</i></sup> intestinal sections. …”
-
214
-
215
-
216
-
217
-
218
-
219
Hypoxia decreases H3-Ace and increases HDAC1 expression.
Published 2013“…*<i>P</i><0.05, **<i>P</i><0.01 as compared with Sham; #<i>P</i><0.05, ##<i>P</i><0.01 as compared with H24 h. (<b>C, D</b>) ChIP and q-PCR analysis were performed with an anti-H3-Ace antibody and primers amplifying the NEP promoter-1 and promoter-2 regions; the bands illustrate the levels of H3-Ace in the NEP promoter-1 and promoter-2 regions. …”
-
220